These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32828220)

  • 1. Improving Academic Biobank Value and Sustainability Through an Outputs Focus.
    Rush A; Catchpoole DR; Ling R; Searles A; Watson PH; Byrne JA
    Value Health; 2020 Aug; 23(8):1072-1078. PubMed ID: 32828220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next Chapter of the Taiwan Biobank: Sustainability and Perspectives.
    Lin JC; Chen LK; Hsiao WW; Fan CT; Ko ML
    Biopreserv Biobank; 2019 Apr; 17(2):189-197. PubMed ID: 30715914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Approach to Evaluate the Costs and Outputs of Academic Biobanks.
    Rush A; ; Catchpoole DR; Watson PH; Byrne JA
    Biopreserv Biobank; 2024 Apr; ():. PubMed ID: 38666406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A framework for biobank sustainability.
    Watson PH; Nussbeck SY; Carter C; O'Donoghue S; Cheah S; Matzke LA; Barnes RO; Bartlett J; Carpenter J; Grizzle WE; Johnston RN; Mes-Masson AM; Murphy L; Sexton K; Shepherd L; Simeon-Dubach D; Zeps N; Schacter B
    Biopreserv Biobank; 2014 Feb; 12(1):60-8. PubMed ID: 24620771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biobanking 3.0: evidence based and customer focused biobanking.
    Simeon-Dubach D; Watson P
    Clin Biochem; 2014 Mar; 47(4-5):300-8. PubMed ID: 24406300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
    Seiler CY; Eschbacher J; Bowser R; LaBaer J
    Biopreserv Biobank; 2015 Dec; 13(6):401-9. PubMed ID: 26697909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustainability of Biobanks in the Future.
    De Souza YG
    Adv Exp Med Biol; 2015; 864():29-35. PubMed ID: 26420611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practical use of biobank information management system (BIMS) for clinical-biological annotations in biobanks].
    Le Queau C; Ann Phillips W; Srinivasan A
    Med Sci (Paris); 2020 Mar; 36(3):285-288. PubMed ID: 32228852
    [No Abstract]   [Full Text] [Related]  

  • 16. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
    Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
    Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing Cooperation Between Academic Biobanks and Biomedical Industry: Better Mutual Understanding and New Collaborative Models Are Needed.
    Simeon-Dubach D; Roehrl MH; Hofman P; Puchois P
    Biopreserv Biobank; 2020 Apr; 18(2):144-149. PubMed ID: 32043910
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost model for biobanks.
    Gonzalez-Sanchez MB; Lopez-Valeiras E; Morente MM; Fernández Lago O
    Biopreserv Biobank; 2013 Oct; 11(5):272-7. PubMed ID: 24835258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial stability in biobanking: unique challenges for disease-focused foundations and patient advocacy organizations.
    Bromley RL
    Biopreserv Biobank; 2014 Oct; 12(5):294-9. PubMed ID: 25313427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Model to Estimate Frozen Tissue Collection Targets in Biobanks to Support Cancer Research.
    Meredith AJ; Slotty A; Matzke L; Babinszky S; Watson PH
    Biopreserv Biobank; 2015 Oct; 13(5):356-62. PubMed ID: 26418967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.